Intracellular delivery of antibodies by chimeric Sesbania mosaic virus (SeMV) virus like particles

被引:37
|
作者
Abraham, Ambily [1 ]
Natraj, Usha [1 ]
Karande, Anjali A. [1 ,2 ]
Gulati, Ashutosh [2 ]
Murthy, Mathur R. N. [2 ]
Murugesan, Sathyabalan [3 ]
Mukunda, Pavithra [3 ]
Savithri, Handanahal S. [1 ]
机构
[1] Indian Inst Sci, Dept Chem, Bangalore, Karnataka, India
[2] Indian Inst Sci, Mol Biophys Unit, Bangalore, Karnataka, India
[3] Theramyt Novobiol Pvt Ltd, Bangalore, Karnataka, India
来源
SCIENTIFIC REPORTS | 2016年 / 6卷
关键词
VIRAL NANOPARTICLES; PROTEIN-A; MONOCLONAL-ANTIBODIES; STAPHYLOCOCCUS-AUREUS; IN-VITRO; THERAPY; CANCER; CELLS; TRASTUZUMAB; FRAGMENT;
D O I
10.1038/srep21803
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The therapeutic potential of antibodies has not been fully exploited as they fail to cross cell membrane. In this article, we have tested the possibility of using plant virus based nanoparticles for intracellular delivery of antibodies. For this purpose, Sesbania mosaic virus coat protein (CP) was genetically engineered with the B domain of Staphylococcus aureus protein A (SpA) at the beta H-beta I loop, to generate SeMV loop B (SLB), which self-assembled to virus like particles (VLPs) with 43 times higher affinity towards antibodies. CP and SLB could internalize into various types of mammalian cells and SLB could efficiently deliver three different monoclonal antibodies-D6F10 (targeting abrin), anti-a-tubulin (targeting intracellular tubulin) and Herclon (against HER2 receptor) inside the cells. Such a mode of delivery was much more effective than antibodies alone treatment. These results highlight the potential of SLB as a universal nanocarrier for intracellular delivery of antibodies.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Complete nucleotide sequence of Sesbania mosaic virus:: a new virus species of the genus Sobemovirus
    Lokesh, GL
    Gopinath, K
    Satheshkumar, PS
    Savithri, HS
    ARCHIVES OF VIROLOGY, 2001, 146 (02) : 209 - 223
  • [32] Recombinant virus like particles as drug delivery system
    Georgens, C
    Weyermann, J
    Zimmer, A
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2005, 6 (01) : 49 - 55
  • [33] Virus-like particles as drug delivery vectors
    Zdanowicz, Michal
    Chroboczek, Jadwiga
    ACTA BIOCHIMICA POLONICA, 2016, 63 (03) : 469 - 473
  • [34] Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles
    Zvirbliene, A.
    Samonskyte, L.
    Gedvilaite, A.
    Voronkova, T.
    Ulrich, R.
    Sasnauskas, K.
    JOURNAL OF IMMUNOLOGICAL METHODS, 2006, 311 (1-2) : 57 - 70
  • [35] INTERACTIONS OF RIBONUCLEOTIDE POLYMERS WITH TOBACCO MOSAIC VIRUS PROTEIN TO FORM VIRUS-LIKE PARTICLES
    HART, RG
    SMITH, JD
    NATURE, 1956, 178 (4536) : 739 - 740
  • [36] Engineering Tobacco Mosaic Virus and Its Virus-Like-Particles for Synthesis of Biotemplated Nanomaterials
    Lee, Kok Zhi
    Basnayake Pussepitiyalage, Vindula
    Lee, Yu-Hsuan
    Loesch-Fries, L. Sue
    Harris, Michael T.
    Hemmati, Shohreh
    Solomon, Kevin V.
    BIOTECHNOLOGY JOURNAL, 2021, 16 (04)
  • [37] Crystal Structure and Proteomics Analysis of Empty Virus-like Particles of Cowpea Mosaic Virus
    Huynh, Nhung T.
    Hesketh, Emma L.
    Saxena, Pooja
    Meshcheriakova, Yulia
    Ku, You-Chan
    Hoang, Linh T.
    Johnson, John E.
    Ranson, Neil A.
    Lomonossoff, George P.
    Reddy, Vijay S.
    STRUCTURE, 2016, 24 (04) : 567 - 575
  • [38] Structure of sesbania mosaic virus at 2.8 angstrom resolution.
    Murthy, MRN
    Bhuvaneshwari, M
    Prakash, B
    Gopinath, K
    Savithri, HS
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1996, 65 : SD101 - SD101
  • [39] STRUCTURE OF SESBANIA MOSAIC-VIRUS AT 3 ANGSTROM RESOLUTION
    BHUVANESHWARI, M
    SUBRAMANYA, HS
    GOPINATH, K
    SAVITHRI, HS
    NAYUDU, MV
    MURTHY, MRN
    STRUCTURE, 1995, 3 (10) : 1021 - 1030
  • [40] Biodistribution and toxicity evaluation of sesbania mosaic virus nanoparticles in mice
    Vardhan, G. P. Vishnu
    Savithri, H. S.
    Murthy, M. R. N.
    Hema, M.
    ARCHIVES OF VIROLOGY, 2016, 161 (10) : 2673 - 2681